tiprankstipranks
Nexien BioPharma Inc (NXEN)
OTHER OTC:NXEN
US Market

Nexien BioPharma (NXEN) Stock Price & Analysis

5 Followers

NXEN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.10
Previous Close$0.02
Volume9.00K
Average Volume (3M)11.98K
Market Cap
$1.10M
Enterprise Value$1.35M
Total Cash (Recent Filing)$68.99K
Total Debt (Recent Filing)$213.00K
Price to Earnings (P/E)-4.5
Beta-0.60
Nov 14, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding67,472,196
10 Day Avg. Volume8,602
30 Day Avg. Volume11,981
Standard Deviation0.47
R-Squared0.04
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-5.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

NXEN FAQ

What was Nexien BioPharma Inc’s price range in the past 12 months?
Nexien BioPharma Inc lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
    What is Nexien BioPharma Inc’s market cap?
    Currently, no data Available
    When is Nexien BioPharma Inc’s upcoming earnings report date?
    Nexien BioPharma Inc’s upcoming earnings report date is Nov 14, 2018 which is 2014 days ago.
      How were Nexien BioPharma Inc’s earnings last quarter?
      Currently, no data Available
      Is Nexien BioPharma Inc overvalued?
      According to Wall Street analysts Nexien BioPharma Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nexien BioPharma Inc pay dividends?
        Nexien BioPharma Inc does not currently pay dividends.
        What is Nexien BioPharma Inc’s EPS estimate?
        Nexien BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nexien BioPharma Inc have?
        Nexien BioPharma Inc has 67,472,200 shares outstanding.
          What happened to Nexien BioPharma Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nexien BioPharma Inc?
          Currently, no hedge funds are holding shares in NXEN
          ---

          Nexien BioPharma Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -57.50%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -75.48%
          Trailing 12-Months

          Company Description

          Nexien BioPharma Inc

          Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. It also invests in companies with technologies or medications focused on cannabinoid-based research. The company was founded in 1952 and is headquartered in Glendale, CO.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Advaxis
          Agenus
          Amarin
          ADMA Biologics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis